Guizhou Maoxiang Pharmaceutical

Guizhou Maoxiang Pharmaceutical is a pharmaceutical manufacturing company based in Guiyang, China, specializing in Traditional Chinese Medicine (TCM) and chemical generic drugs. The company's product portfolio includes over 60 national drug approval numbers, covering therapeutic areas such as cardiovascular health, respiratory diseases, and digestive disorders. In June 2014, the company was fully acquired by Guizhou Bailing Group Pharmaceutical Co., Ltd. for approximately 142 million RMB. This acquisition allowed the parent company to integrate Maoxiang's production capacities and expand its market share in the TCM sector. Maoxiang operates multiple GMP-certified production lines for various dosage forms, including tablets, capsules, and granules. The company remains an active subsidiary, contributing to the broader healthcare offerings of the Bailing Group in the Chinese domestic market.